Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, et al: The global burden of diabetic foot disease. .Lancet 366::1719. ,2005. .
Singh N, Armstrong DG, Lipsky BA: Preventing foot ulcers in patients with diabetes. .JAMA 293::217. ,2005. .
Posnett J, Franks PJ: The burden of chronic wounds in the UK. .Nurs Times 104::44. ,2008. .
Diegelmann RF: Excessive neutrophils characterize chronic pressure ulcers. .Wound Rep Reg 11::490. ,2003. .
Amano S, Ogura Y, Akutsu N, et al: Protective effect of matrix metalloproteinase inhibitors against epidermal basement membrane damage: skin equivalents partially mimic photoageing process. .Br J Dermatol 153: (suppl 2) :37. ,2005. .
Dorsett-Martin WA: Rat models of skin wound healing: a review. .Wound Rep Reg 12::591. ,2004. .
Galeano M, Altavilla D, Cucinotta D, et al: Recombinant human erythropoietin stimulates angiogenesis and wound healing in the genetically diabetic mouse. .Diabetes 53::2509. ,2004. .
Jacobi J, Jang JJ, Sundram U, et al: Nicotine accelerates angiogenesis and wound healing in genetically diabetic mice. .Am J Pathol 161::97. ,2002. .
Nwomeh BC, Yager DR, Cohen IK: Physiology of the chronic wound. .Clin Plast Surg 25::341. ,1998. .
Menke NB, Ward KR, Witten TM, et al: Impaired wound healing. .Clin Dermatol 25::19. ,2007. .
Varani J, Warner RL, Gharaee-Kermani M, et al: Vitamin A antagonizes decreased cell growth and elevated collagen-degrading matrix metalloproteinases and stimulates collagen accumulation in naturally aged human skin. .J Invest Dermatol 114::480. ,2000. .
Davis GE, Saunders WB: Molecular balance of capillary tube formation versus regression in wound repair: role of matrix metalloproteinases and their inhibitors. .J Investig Dermatol Symp Proc 11::44. ,2006. .
Armstrong DG, Jude EB: The role of matrix metalloproteinases in wound healing. .JAPMA 92::12. ,2002. .
Soo C, Shaw WW, Zhang X, et al: Differential expression of matrix metalloproteinases and their tissue-derived inhibitors in cutaneous wound repair. .Plast Reconstr Surg 105::638. ,2000. .
Ladwig GP, Robson MC, Liu R, et al: Ratios of activated matrix metalloproteinase-9 to tissue inhibitor of matrix metalloproteinase-1 in wound fluids are inversely correlated with healing of pressure ulcers. .Wound Rep Reg 10::26. ,2002. .
Lerman OZ, Galiano RD, Armour M, et al: Cellular dysfunction in the diabetic fibroblast: impairment in migration, vascular endothelial growth factor production, and response to hypoxia. .Am J Pathol 162::303. ,2003. .
Manuel JA, Gawronska-Kozak B: Matrix metalloproteinase 9 (MMP-9) is upregulated during scarless wound healing in athymic nude mice. .Matrix Biol 25::505. ,2006. .
Background: We investigated the mechanism of delayed would healing caused by diabetes and measured the dynamic changes in matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of metalloproteinase 1 (TIMP-1) levels. We noted differences in the ratio of MMP-9 to TIMP-1 in the wounds of diabetic and nondiabetic rats.
Methods: Forty-two Sprague-Dawley rats weighing 250 g were randomly assigned to either the control group or the streptozotocin-induced diabetes group. Then, full-thickness excision wounds were created on the middle of the back of each animal. Skin biopsy specimens were obtained on days 0, 3, 7, and 14 after incision. The content of collagen was quantified by Masson’s staining and the macrophage marker, and CD68 was detected by immunohistochemical analysis. Messenger RNA and protein expression of MMP-9 and TIMP-1 was measured by reverse transcriptase–polymerase chain reaction and Western blot, respectively.
Results: Diabetic rats exhibited slower wound healing than control animals (P < .05). On days 3, 7, and 14 after incision, higher levels of MMP-9 messenger RNA and protein expression were detected in the diabetic group compared with the control group (P < .05), and expression of TIMP-1 messenger RNA and protein was significantly decreased. In addition, the ratio of MMP-9 to TIMP-1 was stable in controls, whereas there was a marked increase in the ratio in diabetic skin wounds.
Conclusions: The balance between MMP-9 and its inhibitor, TIMP-1, is disturbed in diabetic skin tissue after injury, which may lead to histologic abnormality of diabetic skin and delayed wound healing. (J Am Podiatr Med Assoc 99(6): 489–496, 2009)